.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Teva
QuintilesIMS
Novartis
Express Scripts
Harvard Business School
Fuji
Healthtrust
Mallinckrodt

Drugs facing the most patent expirations this year

Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities.

Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril from loss of patent protection.

This chart shows which pharmaceutical companies face the most patent expirations this year.

The drug companies facing the most patent expirations this year are:

Back to Pharmaceutical Industry Infographics

For more information try a trial or see the database preview and plans and pricing

botpot